In utero administration of a gene-editing technology in a mouse model has been able to correct a mutation that causes fatal respiratory failure in the animals within hours of birth if left untreated. For now, the work is proof of concept, and survival rates in treated animals remained low. But the fact that prenatal gene editing was able to prevent an otherwise lethal disease at all has encouraging implications.